Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/PYXS/Revenue

Pyxis Oncology, Inc. (PYXS) Revenue 2024–2025

Pyxis Oncology, Inc. (PYXS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$13.9MFY2025 · since FY2024: $16.1M → $13.9M
2425
Fiscal yearValueYoY
FY2025$13.9M-14.2%
FY2024$16.1M—

Source: SEC XBRL filings · For reference only · Not investment advice

More PYXS financial trends

PYXS Net incomePYXS Net marginPYXS Gross profitPYXS Gross marginPYXS Operating incomePYXS Operating marginPYXS Operating cash flowPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →